Vascular endothelial growth factor induces endothelial fenestrations in vitro. - Wikidata - awgldk - TriplyDB

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

http://www.wikidata.org/entity/Q42112888

about

PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters Establishment of a human in vitro model of the outer blood-retinal barrier Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?A brief overview of preeclampsia Is inflammation the cause of pre-eclampsia?Choroid plexus in developmental and evolutionary perspective Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2 Identification and cloning of an 85-kDa protein homologous to RING3 that is upregulated in proliferating endothelial cells Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice Choline plasmalogens isolated from swine liver inhibit hepatoma cell proliferation associated with caveolin-1/Akt signaling MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α A potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli Angiopoietin 2 alters pancreatic vascularization in diabetic conditions The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells.Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma.Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface.How molecular microscopy revealed new insights into the dynamics of hepatic endothelial fenestrae in the past decade.Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.Pre-eclampsia part 1: current understanding of its pathophysiology.Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.Influence of host microvascular environment on tumour vascular endothelium.VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas.Choroid plexus in the central nervous system: biology and physiopathology.Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function Vascular endothelial growth factors and vascular permeability The central role of antigen presentation in islets of Langerhans in autoimmune diabetes Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus.Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

P2860

Q24293773-024E56EF-28BB-4179-97CD-1140F85C47BE Q24295296-B9C3B5B7-877C-4074-BB44-DED40236B380 Q24559732-19FE3261-437A-4B7F-92DC-76938B0088A3 Q24642190-19611B57-9C4D-4336-9D89-F62F588AC754 Q24644639-605A2797-E041-4896-8600-F808273182AD Q24805588-8BFCD27E-04A2-4FB7-B2AE-563B42336DEF Q26773296-82BF9486-29B0-4107-A744-50D5EC67DD94 Q27003730-3EB15123-2116-4893-9BD4-B1BBCDDA716F Q27007059-FFD2CC09-EC52-4B29-A583-F0FA07A8F47B Q27011140-E4C33CCD-85BB-4C20-9515-C7A617D4E4B9 Q28137762-6CE4D696-B855-425A-A8AA-41EE238E03F8 Q28212434-47B01366-1F59-4C92-B807-318734A43EE9 Q28265835-A3E0A455-F905-40B9-BBB4-39E9B9BCE682 Q28382772-943C09FF-7845-4DBA-86FB-4D1D14724F14 Q28534403-BA7C27AA-4AF6-4EA1-9AE3-093A5FF80371 Q28542821-4714AA33-7784-4077-8D6F-E249899DFF4F Q28567391-9193B7F1-E685-43EC-81C3-B66840F271D1 Q28580746-7B59D825-8565-46D4-B01F-E2E337613CAC Q28587327-FBF38AEE-6AA4-44DD-B123-8C6CF82D23C7 Q28732767-4355E7AC-ABB5-4C05-8C37-7FE1686930F9 Q30482967-DCD6D9C8-02A3-4ACE-8E5E-0F636123E8A6 Q30762103-885F3518-083F-4A35-B2E2-EA3E3F1E1B74 Q31074551-B029E4EA-4622-492D-B6AE-A281298E5EF4 Q31081664-6A3490E6-4EEF-4580-A3D1-A9DF3D7697B1 Q33200943-30D01B81-5DBF-4194-84FC-B537B2932863 Q33209360-FEAA12F5-B954-4D2D-AD14-0851B038A388 Q33288440-925D9E9B-FB2C-482D-8CE1-B3E18ADC9CF5 Q33416340-DA266C13-7228-4AAE-BFD8-9D8B5276D368 Q33615441-8F819BC1-E3F5-42D9-8836-C41352E7BAB1 Q33648688-C2339BB2-7401-438B-91FB-C3BB1A2002D9 Q33655353-033D6901-2483-46E1-9389-3A7A5207EBB9 Q33748993-37CF0B53-7A68-44E6-9FAF-8EB3F0D80931 Q33848248-423033FF-9434-4409-82CA-DA3C8EEBBF6C Q33910198-CE3C357B-79E2-43C9-8765-898B8CEBB70B Q33912033-A32F4D6F-D973-474D-8B76-729ED68388CD Q33954958-7881ABF9-5DB0-4A0F-BCBC-8CDCF336C350 Q33986306-78CBAFEF-1F16-4C41-8DA2-35C2052D93FA Q34006777-19B4395B-5AF3-4183-B1AD-5CCFA6539C74 Q34083937-2A524F88-B572-4730-BD2A-595A6ABBDD5D Q34103169-58F7B42A-C420-4EC0-A71C-3E8519F67281

P2860

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

http://www.wikidata.org/entity/Q42112888

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@en

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@nl

type

label

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@en

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@nl

prefLabel

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@en

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@nl

P1433

Q42112888-43609986-AE51-419A-91B8-D14EB939ABF3

P1476

Q42112888-D0A6D7F9-505C-41B5-911C-FE69E932AFED

P2093

Q42112888-5A6CC8B4-82FF-40FF-BF46-E13496492BAB

Q42112888-6B40B5D3-6CEB-4642-A3E6-38665AC8911E

Q42112888-6F7EC7E8-7C0B-489B-AC48-AF07EE7F4FE1

Q42112888-88532276-9357-4F93-BA0F-BCB68D3AC74E

Q42112888-A432572F-E72E-4FDF-9111-67F08BB28BF7

Q42112888-D4607280-DC02-4F8E-B4BF-6BFFC502C4E0

P2860

Q42112888-004892D9-9269-4A5F-8A82-4AD7F69F1DE8

Q42112888-01EB5F2A-6604-437A-A35D-673FDD5EDDE7

Q42112888-02B670BF-8792-4C3E-B9E5-F23F7D9DB4EF

Q42112888-03DDD141-E0AB-4FFE-820F-6A4DA25A7E32

Q42112888-0610A439-58FD-449A-A1A7-A2DCA006ACB6

Q42112888-0A440047-B9DD-460E-95A7-76F020124628

Q42112888-0BD3473A-12BA-4A78-AEE2-6B7F115FA104

Q42112888-0BDB75AE-254F-499F-8B00-FC48EE02CE18

Q42112888-13F4BFF3-C24A-47C5-B711-FC82DD81C08C

Q42112888-1A67EF1A-1EAC-4940-BB0B-B543E13EAF1C

P304

Q42112888-B7499212-BA09-4FFB-B906-45BC58947850

P31

Q42112888-19663524-47C1-4435-8EC2-564490F1BF97

P356

Q42112888-C70F36DD-8C38-416C-A68D-B57F3C8C49F2

P407

Q42112888-FB6BDE55-E2F0-40B9-8EC5-72EE2570A32E

P433

Q42112888-C44547F6-0F03-477E-8825-44DD16209F1D

P478

Q42112888-EC1D0DC2-8940-466B-A67C-5ED59BA33F4B

P577

Q42112888-3CF092B6-F930-42BA-BAE1-0C1CDE0C5636

P5875

Q42112888-44356E7A-0BFA-4DFB-8923-82245008169F

P698

Q42112888-511FC6B1-D62C-4DCB-B807-98A898A03610

P921

Q42112888-1C3EF27D-8CA0-4C5A-A184-6A107CA88F89

P932

Q42112888-0B002DB2-291B-426B-AB62-193946BA6FF1

P356

P1433

Journal of Cell Biology

P1476

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

@en

P2093

G Breier

http://www.w3.org/2001/XMLSchema#string

H Wolburg

http://www.w3.org/2001/XMLSchema#string

K Wolburg

http://www.w3.org/2001/XMLSchema#string

S Esser

http://www.w3.org/2001/XMLSchema#string

T Kurzchalia

http://www.w3.org/2001/XMLSchema#string

W Risau

http://www.w3.org/2001/XMLSchema#string

P2860

Identification, sequence, and expression of caveolin-2 defines a caveolin gene family

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

VIP21/caveolin is a cholesterol-binding protein

A novel endothelial-specific membrane protein is a marker of cell-cell contacts

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle

Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins

Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation

P304

947-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.140.4.947

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P577

1998-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274151079

http://www.w3.org/2001/XMLSchema#string

P698

9472045

http://www.w3.org/2001/XMLSchema#string

P921

P932

2141756

http://www.w3.org/2001/XMLSchema#string